Neuranix

Private

NaplesHealthcare & Life Scienceshttps://neuranix.com/

Last Round

VC Round

Jun 1, 2022

Total Funding Raised

$650,000

Company Overview

Neuranix is a diagnostic equipment company that develops and produces diagnostic devices for pathologies of the middle ear for both human and veterinary use.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

middle ear diagnosticsdiagnostic deviceacoustic immittancePLAIpressureless acoustic immittancemedtechnon-invasive diagnosticstympanometry alternativeveterinary diagnosticshandheld medical devicevet techpediatric audiologyENT diagnosticsmedical hardwareAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuranix Comps

Public and private peers based on sector, stage, and business model.

Neuranix comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neuranix Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jun 1, 2022
Seed	Aug 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Filip M.

Founder, CEO & Chairman Of The Board

Founding Team

Matteo Manente

Chief Technology Officer

Executive Team

Neuranix Investors

Notable investors and investment history

Neuranix investors
Investor	Rounds
Bios Line Holding	VC Round
European Regional Development Fund	Grant
CDP Venture Capital SGR	Seed
Kolind A/S	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 21, 2026
Monthly visitors grew 267% MoM.
Mar 23, 2025
Monthly visitors grew 53% MoM.

View all signals

Neuranix Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Neuranix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neuranix's valuation, stock price, and market status.

Firmographic Details

HeadquartersNaples

Employee Range12

Year Founded2017

Last FundingJun 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.